Precision Medicine on SoloSoft

dPCR Market to Surpass US$14.34 Billion by 2031, Driven by Demand for High-Preci

Mon, 01 Jan 0001 00:00:00 +0000

BLUF (Bottom Line Up Front)

The global dPCR (digital PCR) market is rapidly climbing from US$7.52 billion (2024) to US$14.34 billion (2031), with a compound annual growth rate of 9.4%. This is not just a numbers game; it marks the transition of precision genetic analysis from academic research into mainstream clinical practice. Driven by three major forces—cancer liquid biopsy, infectious disease monitoring, and personalized medicine—dPCR is no longer a mere “upgrade” of traditional PCR but a key technology ushering in a new era of molecular diagnostics. Taiwan’s biotechnology industry and semiconductor supply chain must recognize the industrial restructuring opportunities brought by this wave of absolute quantification capability.

Global Life Science IT Market to Reach $62.5 Billion by 2033, Growing 11% Annual

Mon, 01 Jan 0001 00:00:00 +0000

Why Can the Life Science IT Market Triple in a Decade?

The explosion of the life science IT market is no accident but an inevitable result of multiple technologies and demands converging. First, AI and machine learning have moved from labs to clinical applications, from drug molecule screening to medical image interpretation, significantly shortening R&D cycles. Second, the cost of gene sequencing continues to drop, with a single human genome sequencing now costing a few hundred dollars, yet the data generated grows at the petabyte level, which traditional IT architectures cannot handle. Finally, global regulatory agencies are increasingly demanding transparency and traceability in clinical trial data, driving pharmaceutical companies to invest in modern IT systems.